Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, García-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF. Recker RR, et al. Among authors: hartl f. J Bone Miner Res. 2008 Jan;23(1):6-16. doi: 10.1359/jbmr.070906. J Bone Miner Res. 2008. PMID: 17892374 Free article. Clinical Trial.
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.
Goldhahn J, Scheele WH, Mitlak BH, Abadie E, Aspenberg P, Augat P, Brandi ML, Burlet N, Chines A, Delmas PD, Dupin-Roger I, Ethgen D, Hanson B, Hartl F, Kanis JA, Kewalramani R, Laslop A, Marsh D, Ormarsdottir S, Rizzoli R, Santora A, Schmidmaier G, Wagener M, Reginster JY. Goldhahn J, et al. Among authors: hartl f. Bone. 2008 Aug;43(2):343-347. doi: 10.1016/j.bone.2008.04.017. Epub 2008 May 7. Bone. 2008. PMID: 18544475 Review.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators. Reid DM, et al. Among authors: hartl f. Lancet. 2009 Apr 11;373(9671):1253-63. doi: 10.1016/S0140-6736(09)60250-6. Lancet. 2009. PMID: 19362675 Clinical Trial.
Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women.
Krieg MA, Cornuz J, Ruffieux C, Sandini L, Büche D, Dambacher MA, Hartl F, Häuselmann HJ, Kraenzlin M, Lippuner K, Neff M, Pancaldi P, Rizzoli R, Tanzi F, Theiler R, Tyndall A, Wimpfheimer K, Burckhardt P. Krieg MA, et al. Among authors: hartl f. J Bone Miner Res. 2003 Jul;18(7):1261-6. doi: 10.1359/jbmr.2003.18.7.1261. J Bone Miner Res. 2003. PMID: 12854836 Free article.
Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study.
Krieg MA, Cornuz J, Ruffieux C, Van Melle G, Büche D, Dambacher MA, Hans D, Hartl F, Häuselmann HJ, Kraenzlin M, Lippuner K, Neff M, Pancaldi P, Rizzoli R, Tanzi F, Theiler R, Tyndall A, Wimpfheimer C, Burckhardt P. Krieg MA, et al. Among authors: hartl f. J Bone Miner Res. 2006 Sep;21(9):1457-63. doi: 10.1359/jbmr.060615. J Bone Miner Res. 2006. PMID: 16939404 Free article.
Quality controls for two heel bone ultrasounds used in the Swiss Evaluation of the Methods of Measurement of Osteoporotic Fracture Risk Study.
Krieg MA, Cornuz J, Hartl F, Kraenzlin M, Tyndall A, Häuselmann HJ, Lippuner K, Rizzoli R, Büche D, Theiler R, Dambacher MA, Neff M, Pancaldi P, Tanzi F, Wimpfheimer K, Burckhardt P. Krieg MA, et al. Among authors: hartl f. J Clin Densitom. 2002 Winter;5(4):335-41. doi: 10.1385/jcd:5:4:335. J Clin Densitom. 2002. PMID: 12665633
461 results